Pharmacology Biochemical Pharmacology

Poria-derived poricoic acid A restores paclitaxel response in stressed breast cancer mice

  • In mouse breast cancer models, emotional distress sped up tumor growth and blunted the effect of paclitaxel.
  • Poricoic acid A, a triterpenoid from Poria cocos, eased depressive-like behavior and brought paclitaxel sensitivity back; at the high dose, the combination gave the strongest tumor suppression, with no obvious systemic toxicity.
  • The compound appears to act on neuropeptide Y receptor 1, blocking NPY-driven ERK activation and boosting paclitaxel-induced apoptosis, which links distress to chemoresistance through a neuro-tumor axis.
Points Based on the abstract

Before anyone chases NPY1R here, I'd want proof the compound actually binds it. A crude-ish triterpenoid that also lifts mood-like behavior could be hitting many targets, and a receptor antagonist or knockdown rescue is the missing control. Also ask what plasma and brain exposure the high dose gives, and whether paclitaxel alone in unstressed mice is the right benchmark. Mouse-only, so human NPY1R evidence is the real gate.